There are 3164 resources available
Designing protein degraders for cancer treatment
Presenter: Zoran Rankovic
Session: Protein degradation as a novel approach for cancer therapy
Resources:
Slides
Webcast
Understanding the support you need to build your career
Presenter: Angela Lamarca
Session: YO Forum - Finding your “X-factor”: Skills for professional development
Resources:
Slides
Webcast
A cent: A model for person-cantered care in allogenic stem cell transplantation
Presenter: Jeanette Winterling
Session: Rehabilitation and survivorship care
Resources:
Slides
Webcast
MDT: Breast cancer - Case of an older adult with metastatic breast cancer
Session: ESMO-SIOG: Working together in the era of personalized care for older adults with cancer
Resources:
Webcast
Managing long-term treatment sequelae
Presenter: Charlée Nardin
Session: Survivors of advanced melanoma: Management and support
Resources:
Slides
Webcast
Specifics of CHMP assessment of cancer drugs
Presenter: Aaron Sosa Mejia
Session: ESMO-CDDF – Regulatory challenges in clinical cancer drug development
Resources:
Slides
Webcast
1171MO - AI-derived diagnostic criteria for early lung cancer screening using primary care health records
Presenter: Andrew Houston
Session: Mini oral session: Basic science & Translational research
Resources:
Abstract
Slides
Webcast
349MO - Results from a phase Ia/Ib Study of ESG401, a novel Trop2 antibody-drug conjugate, in patients with different subtypes of metastatic breast cancer
Presenter: Fei Ma
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
LBA84 - TAR-200 plus cetrelimab (CET) or CET alone as neoadjuvant therapy in patients (pts) with muscle-invasive bladder cancer (MIBC) who are ineligible for or refuse neoadjuvant cisplatin-based chemotherapy (NAC): Interim analysis of SunRISe-4 (SR-4)
Presenter: Andrea Necchi
Session: Proffered Paper session 2: GU, non-prostate
Resources:
Abstract
Slides
Webcast
Consolidation in oligo-persistent
Presenter: Matthias Guckenberger
Session: Improving outcome in long-term survivors with metastatic NSCLC
Resources:
Slides
Webcast